Prolyl hydroxylase-1 regulates hepatocyte apoptosis in an NF-κB-dependent manner,
Introduction
The chemical reduction of molecular oxygen is central to eukaryotic metabolism. Hypoxia therefore represents a significant threat to bioenergetic homeostasis and cell survival.
Eukaryotic cells evolved an adaptive transcriptional response to hypoxia which is mediated primarily by the hypoxia inducible factor (HIF) [1] . The enzymes responsible for conferring hypoxic sensitivity upon HIF are termed prolyl hydroxylases (PHDs) [1] .
A second key hypoxia-sensitive transcription factor is NF-kappaB (NF-κB). In unstimulated cells, NF-κB is retained in the cytoplasm by IkappaB (IκB) proteins [2] . Upon stimulation of cells by pro-inflammatory signals, IκB is phosphorylated by IκB kinase (IKK) targeting it for proteasomal degradation. Liberated NF-κB dimers then translocate to the nucleus and regulate transcription of a range of genes including a number associated with the regulation of apoptosis [3] . Hypoxia regulates NF-κB activity in a hydroxylase-dependent manner although this is a complex relationship. In the basal state, hydroxylase inhibition induces a low level activation of NF-κB, whereas in cells stimulated with Interleukin-1beta (IL-1β), hydroxylase inhibition suppresses NF-κB [4, 5] .
Pharmacologic hydroxylase inhibition is protective in a number of models of intestinal inflammation [6] [7] [8] [9] [10] [11] [12] [13] . Based on experiments utilizing isoform-specific PHD knock-out mice, it was shown that knock-out of PHD1 (but not PHD2 or PHD3) is responsible for protection against the development of colitis through inhibition of apoptosis in epithelial cells and consequent improvement in intestinal barrier function [14] . Hepatocytes also express functional PHD1 and PHD1 knock-out mice are protected against liver ischemia/reperfusion injury in a manner which is associated with reduced hepatocyte apoptosis [15] . However, the molecular mechanisms linking PHD-1 activity and apoptosis remain unclear and are the topic of this study.
Materials and Methods
Reagents. All chemicals were obtained from Sigma Aldrich except DMOG (Cayman Chemicals). FLAG-EGLN2 was from William Kaelin (Harvard Medical School). FLAG-IKKβ was from Warner Greene (Addgene plasmid #23298) [16] . HIF HepG2 cells were from Bernhard Brüne (University of Frankfurt).
Cell culture. Primary hepatocytes, derived from wild type or PHD1 -/-Swiss/129 mice, Caco-2 , HepG2 and HEK293 cells were cultured using standard conditions. Site directed mutagenesis. The P191A-IKKβ mutant was generated using QuikChange Lightning mutagenesis kit (Agilent Technologies). Forward and reverse primers for IKKβ In vitro transcription/translation. A rabbit reticulocyte-based transcription/translation system was used as per manufacturer's instructions (Promega) using cDNA of FLAG-tagged PHD-1 cloned into pcDNA3 vector or the empty vector alone as template as indicated.
Mass spectrometry.
N-terminally biotinylated synthetic peptides of GSLATSFVGTLQYLAPELLEQQKY (GL Biochem, Shanghai) were incubated with the complete reaction mixture from the in vitro transcription/translation assay as described previously [17] . Peptides were then isolated using monovalent streptavidin resin (Amersham), eluted, desalted and subjected to reverse-phase liquid chromatography coupled to mass spectrometry (LC-MS/MS) as described in [5] . The IKKβ peptide containing the Proline 191 residue was quantified by comparing the XIC of the threefold charged modified peptide and unmodified peptides using a window of 0.02 Da. Normalization of hydroxylated peptide was performed by dividing the intensity of the modified peptide by the matching unmodified peptide.
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A C C E P T E D ACCEPTED MANUSCRIPT 7 genome (mm9). Reads were aligned with BWA aligner [19] . For peak calling, FindPeaks version 4.0 was used with standard parameters for control/case with a p-value cut-off of 0.01 [20] . The overlaps of the peaks were analysed using the R/bioconductor package ChIPpeakAnno [21, 22] . When computing the overlaps between different subunits, the maximum gap allowed between the peaks was 100 base pairs. For the same subunit no gap was permitted. Raw data can be sourced using the following URLs for (1) p50 binding in PHD1-/-cells, (2) p50 binding in WT cells, (3) p65 binding in PHD1-/-cells and (4) p65 binding in WT cells respectively: 
Immunobloting. Analyses were carried out as detailed previously [24] . Primary antibodies used are summarized in Table 1 .
NF-κ κ κ κB luciferase reporter assay. Luciferase reporter assays were carried out as described previously [4, 5] . 
Results

NF-κ κ κ κB activity is elevated in PHD1 -/hepatocytes
Immunohistochemical analysis of liver sections from wild type (WT) and PHD1 -/mice revealed nuclear enrichment of phosphorylated p50 in tissue from PHD1 -/mice compared to WT suggesting that PHD1 depletion leads to the activation of NF-κB in hepatocytes ( Figure   1A ). A potential target for PHD-dependent hydroxylation in the NF-κB pathway is IKKβ as it contains an LxxLAP hydroxylation motif similar to those found in HIFα subunits between amino acids 186 and 191 [4, 18] . This suggests that proline 191 (Pro191) could be a target for functional hydroxylation [4] . Rabbit reticulocyte-translated PHD1 was incubated with a synthetic peptide containing the putative hydroxylation motif of IKKβ. Mass spectrometric analysis revealed increased levels of proline hydroxylated peptide in the samples incubated with PHD1-reticulocyte lysates compared to those incubated with control lysates ( Figure 1B ).
While peptides incubated in control lysates were predominantly in the non-hydroxylated state ( Figure 1C ), peptides incubated with lysates containing PHD1 showed two fractions of comparable abundance ( Figure 1D ). One of these fractions was identified as peptide hydroxylated on the proline residue corresponding to Pro191 of IKKβ. Mass spectrometric analysis also revealed that incubation with reticulocyte lysate resulted in the oxidation of the N-terminal affinity label biotin. In the presence of PHD1 we additionally detected the hydroxylation of Pro191. (Figure 1B,D) .
These in vitro data support the possibility that Pro191 of IKKβ is a target for hydroxylation by PHD1. It is noteworthy that Pro191 hydroxylation was detected in samples incubated in the absence of PHD1 ( Figure 1B) suggesting either that this site is prone to non-enzymatic oxidation or modified by other hydroxylases in the rabbit reticulocyte lysate.
To investigate whether PHD1 alone is sufficient to catalyze IKKβ hydroxylation, we next . In contrast to the experiment in which peptides were incubated with whole reticulocyte lysates, peptide hydroxylation was not consistently detected in the lysate-free hydroxylation assay ( Figure 1F ). This may reflect the requirement for additional co-factors (present in the reticulocyte lysate) which are required for the PHD1-mediated IKKβ hydroxylation but not for HIF-1α hydroxylation. While identifying such factor(s) is beyond the scope of the current manuscript, future studies will be directed towards investigating this important question.
We next investigated a possible functional role for Pro191 in NF-κB signaling. We generated a P191A IKKβ mutant and compared its NF-κB activating potential to WT IKKβ.
Overexpression of WT IKKβ reduced basal levels of IκBα and increased p65 phosphorylation on serine 536 indicating enhanced NF-κB signaling ( Figure 2Α ) [25] . In cells stimulated with TNFα, IκBα degradation and Ser536 phosphorylation of p65 were increased further when WT IKKβ is overexpressed (Figure 2A and 2B) . In contrast, the P191A IKKβ failed to exert similar effects on NF-κB pathway (Figure 2A and 2B ). Overexpression of WT IKKβ also resulted in robustly elevated basal NF-κB activity (as measured by luciferase reporter assay) compared to mock-transfected cells and this activation was refractive to further stimulation by TNFα while the P191A mutant failed to increase basal NF-κB activity and rendered cells unresponsive to TNFα stimulation ( Figure 2C ). These data support the hypothesis that proline 191 of IKKβ is important for the catalytic activity of the kinase. Thus, its PHD1-mediated hydroxylation may affect its critical role in the signal transduction of the canonical NF-κB pathway.
PHD1 knockout changes the DNA binding pattern of NF-κ κ κ κB in primary hepatocytes
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A C C E P T E D ACCEPTED MANUSCRIPT 11 We next employed chromatin immunoprecipitation combined with DNA sequencing (ChIPseq) to determine the distribution of binding sites of the p50 and p65 subunits of NF-κB throughout the genome. We found elevated numbers of binding sites for both p50 and p65 in chromatin from primary hepatocytes derived from PHD1 -/mice compared to WT controls ( Figure 3A) . We identified 3445 and 6945 unique binding sites for p50 and p65, respectively, in PHD1 -/cells compared with 61 and 584 unique binding sites for p50 and p65, respectively, in WT cells. The average relative distances of these binding sites from the nearest transcription factor start site was not significantly different between the wild type and the PHD1 -/-( Figure 3B ). Further analysis identified differential NF-κB binding to chromatin close to a cohort of genes known to be involved in the regulation of apoptosis ( Figure 3C-H) . In some cases, e.g. TRAIL, different peak heights were observed between WT and PHD1 -/cells, indicative of the differential degree of binding. In other cases (e.g. CASPASE-3, CASPASE-6, BIRC2, BIRC4 and FADD) unique binding sites were identified in PHD1 -/cells. It is noteworthy, that unique binding sites for p50 were frequently found in genes considered to be pro-apoptotic whereas p65 was more often enriched proximal to anti-apoptotic genes ( Figure   3C -H).
In order to take an alternative approach to investigating the role of PHD1 in regulating apoptotic gene expression, we next carried out a quantitative PCR-based screening array of a panel of apoptosis-related genes. Using this approach, we identified a cohort of pro-apoptotic genes that are downregulated in HepG2 cells in which PHD1 was knocked down using siRNA compared to mock transfected controls ( Table 1) genome-wide relocation of p50 and p65 in response to inhibition of PHD1 results in differential expression of genes involved in the regulation of apoptosis. Overall, these findings suggest that gene expression is biased toward an anti-apoptotic / pro-survival state upon the inhibition of PHD1 in hepatocytes.
Pharmacological PHD inhibition promotes hepatocyte survival.
To test whether hydroxylase inhibition protects hepatocytes by reducing the rate of apoptosis in an NF-κB-dependent manner, we exposed HepG2 cells to TRAIL in the presence or absence of the hydroxylase inhibitor DMOG and Bay-117082 which inhibits TNFα-induced NF-κB activity in HepG2 cells ( Figure 4A ) [26] . TRAIL profoundly increased apoptosis in a manner that was partially reversed by DMOG treatment. The protective effects of DMOG were reversed by Bay-117082 indicating that NF-κB signaling mediates the anti-apoptotic effect of hydroxylase inhibitors in hepatocytes ( Figure 4B and 4C ). To investigate whether there was also a role for HIF1 or HIF2, we investigated whether the anti-apoptotic effect of DMOG is lost in HIF -/cells. RNA interference-mediated knock-down of either HIF-1 or HIF-2α ( Figure 4D ) had no significant impact on the anti-apoptotic effects of DMOG ( Figure 4E and 4F). These data indicate that the anti-apoptotic effects of the hydroxylase inhibition are independent of the HIF pathway and due instead to the activation of NF-κB.
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Discussion
Recent work has shown that protein hydroxylation is not restricted to HIFα subunits and that components of other pathways such as NF-κB may also be functional targets for hydroxylases [4, 5, [27] [28] [29] . Consistent with these studies, we identified a global increase in NF-κB binding to chromatin in PHD1 -/hepatocytes. This may explain the observed anti-apoptotic effects of hydroxylase inhibition.
Protective effects of PHD1 knockout, due to decreased apoptosis, have been reported in models of colitis and liver ischemia/reperfusion injury [14, 15] . Furthermore, PHD1 -/mice display decreased cardiomyocyte apoptosis and are protected against ischemia reperfusion injury [15, 28, 30] . However, the molecular mechanisms underpinning the link between hydroxylase inhibition and apoptosis is unclear.
In this manuscript, we propose a model whereby PHD1 promotes apoptosis by suppressing NF-κB activity. PHD1 inhibition prevents apoptosis by increasing the activity of IKKβ leading to phosphorylation and degradation of IκB with a resultant increase in NF-κB which upregulates anti-apoptotic genes. Although our data indicate that the IKKβ may be a bona fide target for PHD1, whether this occurs in vivo and is regulated by hypoxia remains to be determined [4, 18] .
The dominant-negative behaviour of the P191A mutant supports the concept that Pro191 is important for the catalytic activity of IKKβ. It was previously demonstrated that the intact Cterminal IKK complex-related phosphor-acceptor site of p105 is a prerequisite for the TNFαresponsive degradation of p105 and the consequent formation of the p50-containing transactivator NF-κB complexes [31] . Since Pro191 is located in the close proximity of the kinase 
